These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
24. A single-arm confirmatory trial of pazopanib in patients with paclitaxel-pretreated primary cutaneous angiosarcoma: Japan Clinical Oncology Group study (JCOG1605, JCOG-PCAS protocol). Oashi K, Shibata T, Namikawa K, Takahashi A, Yokota K, Nakano E, Teramoto Y, Tsutsumida A, Maeda T, Yamazaki N, Dermatologic Oncology Group of the Japan Clinical Oncology Group. BMC Cancer; 2020 Jul 13; 20(1):652. PubMed ID: 32660439 [Abstract] [Full Text] [Related]
25. Paclitaxel in patients with advanced angiosarcomas of soft tissue: a retrospective study of the EORTC soft tissue and bone sarcoma group. Schlemmer M, Reichardt P, Verweij J, Hartmann JT, Judson I, Thyss A, Hogendoorn PC, Marreaud S, Van Glabbeke M, Blay JY. Eur J Cancer; 2008 Nov 13; 44(16):2433-6. PubMed ID: 18771914 [Abstract] [Full Text] [Related]
26. A phase 2 study of GVAX colon vaccine with cyclophosphamide and pembrolizumab in patients with mismatch repair proficient advanced colorectal cancer. Yarchoan M, Huang CY, Zhu Q, Ferguson AK, Durham JN, Anders RA, Thompson ED, Rozich NS, Thomas DL, Nauroth JM, Rodriguez C, Osipov A, De Jesus-Acosta A, Le DT, Murphy AG, Laheru D, Donehower RC, Jaffee EM, Zheng L, Azad NS. Cancer Med; 2020 Feb 13; 9(4):1485-1494. PubMed ID: 31876399 [Abstract] [Full Text] [Related]
28. Pembrolizumab monotherapy versus chemotherapy for treatment of advanced urothelial carcinoma with disease progression during or following platinum-containing chemotherapy. A Cochrane Rapid Review. Narayan V, Kahlmeyer A, Dahm P, Skoetz N, Risk MC, Bongiorno C, Patel N, Hwang EC, Jung JH, Gartlehner G, Kunath F. Cochrane Database Syst Rev; 2018 Jul 23; 7(7):CD012838. PubMed ID: 30036453 [Abstract] [Full Text] [Related]
35. Pembrolizumab with or without radiotherapy for metastatic non-small-cell lung cancer: a pooled analysis of two randomised trials. Theelen WSME, Chen D, Verma V, Hobbs BP, Peulen HMU, Aerts JGJV, Bahce I, Niemeijer ALN, Chang JY, de Groot PM, Nguyen QN, Comeaux NI, Simon GR, Skoulidis F, Lin SH, He K, Patel R, Heymach J, Baas P, Welsh JW. Lancet Respir Med; 2021 May 23; 9(5):467-475. PubMed ID: 33096027 [Abstract] [Full Text] [Related]
36. Pembrolizumab in Microsatellite-Instability-High Advanced Colorectal Cancer. André T, Shiu KK, Kim TW, Jensen BV, Jensen LH, Punt C, Smith D, Garcia-Carbonero R, Benavides M, Gibbs P, de la Fouchardiere C, Rivera F, Elez E, Bendell J, Le DT, Yoshino T, Van Cutsem E, Yang P, Farooqui MZH, Marinello P, Diaz LA, KEYNOTE-177 Investigators. N Engl J Med; 2020 Dec 03; 383(23):2207-2218. PubMed ID: 33264544 [Abstract] [Full Text] [Related]
37. Retrospective analysis of treatment-naive Slovenian patients with metastatic melanoma treated with pembrolizumab - real-world experience. Hribernik N, Boc M, Ocvirk J, Knez-Arbeiter J, Mesti T, Ignjatovic M, Rebersek M. Radiol Oncol; 2020 Jan 19; 54(1):119-127. PubMed ID: 31955148 [Abstract] [Full Text] [Related]